Realising the potential of faecal microbiota transplant.

First reported in Western medical literature in the 1950s, faecal microbiota transplant (FMT) has now come of age as a cost‐effective treatment for recurrent Clostridioides difficile infection. But what do we know about FMT, what are its uses and limitations, and where might microbiome treatments take us in the future? [ABSTRACT FROM AUTHOR]